Seaview Investment Managers LLC Buys Shares of 9,776 McKesson Corporation $MCK

Seaview Investment Managers LLC bought a new stake in McKesson Corporation (NYSE:MCK) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 9,776 shares of the company’s stock, valued at approximately $8,019,000. McKesson makes up 3.0% of Seaview Investment Managers LLC’s portfolio, making the stock its 19th largest holding.

Several other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC raised its stake in shares of McKesson by 46.3% during the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP bought a new stake in shares of McKesson during the 1st quarter worth approximately $233,000. Sivia Capital Partners LLC raised its stake in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock worth $502,000 after purchasing an additional 300 shares in the last quarter. Treasurer of the State of North Carolina raised its stake in shares of McKesson by 0.9% during the 2nd quarter. Treasurer of the State of North Carolina now owns 58,623 shares of the company’s stock worth $42,958,000 after purchasing an additional 508 shares in the last quarter. Finally, Osterweis Capital Management Inc. bought a new stake in shares of McKesson during the 2nd quarter worth approximately $166,000. Institutional investors own 85.07% of the company’s stock.

McKesson Trading Down 0.1%

MCK opened at $765.30 on Tuesday. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The stock’s fifty day simple moving average is $834.66 and its 200 day simple moving average is $855.23. The stock has a market cap of $91.99 billion, a PE ratio of 19.89, a price-to-earnings-growth ratio of 1.14 and a beta of 0.35.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Thursday, May 7th. The company reported $11.69 earnings per share for the quarter, beating analysts’ consensus estimates of $11.56 by $0.13. McKesson had a negative return on equity of 345.35% and a net margin of 1.18%.The business had revenue of $96.30 billion for the quarter, compared to analysts’ expectations of $101.35 billion. During the same quarter in the prior year, the business earned $10.12 EPS. The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Equities analysts forecast that McKesson Corporation will post 44.29 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson’s dividend payout ratio is 8.53%.

Insiders Place Their Bets

In related news, EVP Michele Lau sold 2,725 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on MCK shares. Wells Fargo & Company dropped their price objective on McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Morgan Stanley reiterated an “overweight” rating and set a $966.00 price objective on shares of McKesson in a research note on Thursday, January 29th. Evercore reiterated an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Citigroup dropped their price objective on McKesson from $975.00 to $945.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. Finally, William Blair started coverage on McKesson in a research note on Tuesday, April 28th. They set an “outperform” rating on the stock. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $968.87.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.